Consultant Cardiologist, Awali Hospital, Bahrain
Title: Heart Failure: Management Failures- Who is to be blamed?
Dr Syed Raza graduated from Aligarh University in India in 1993. After completing his postgraduate degree in Medicine from the same university, he moved to the UK for higher specialist studies. He successfully completed MRCP and CCT and later also awarded Fellow of the Royal College of Physicians of Edinburgh. He was awarded professor John Goodwin prize for outstanding performance in Diploma Cardiology exam at Hammersmith Hospital, University of London in 2001. Dr Raza is Fellow of American College of Cardiology , American College of Chest Physicoans as well as Fellow of European Society of Cardiology. He is also on the committee of Acute Cardiovascular Care. Heart Failure and Cardiovascular Imaging ( European Society of Cardiology )
He is currently serving as consultant in Cardiology and Head of the department of Medicine at Awali Hospital, Bahrain. He is the educational coordinator and chairman of resuscitation committee of the hospital. He is the regional coordinator and examiner for MRCP exam for the Royal College of Physicians of Edinburgh. He is external examiner for Arabian Gulf Medical University. He is also the immediate past chairman of Medical Advisory Committee. He has to his credit numerous publications and he has presented his work in different parts of the world. He is peer review author for some well respected International journals.
He is Review author for abstracts for European Society of Cardiology Annual Congress 2018.
Heart failure (HF) remains a major public health problem that has high incidence and prevalence globally. It is the leading cause of hospitalization for people of 65 years of age and older, and rates of hospital readmission within 6 months range from 25% to 50%. The personal burden of HF includes debilitating symptoms, frequent rehospitalizations, and high rates of mortality. HF also poses a substantial economic burden, with annual direct costs for the care of HF patients estimated to be between $20 billion and $56 billion.
A number of studies have documented marked variation in the quality of care judged by specific performance measures and substantial underuse of evidence-based, guideline-recommended HF therapies in patients receiving conventional care. Moreover, patient behavioural factors (such as nonadherence to diet and medications) and economic and social factors frequently contribute to rehospitalizations. The traditional model of care delivery is thought to contribute to frequent hospitalizations because in these brief episodic encounters, little attention may be paid to the common modifiable factors that precipitate many hospitalizations. Patient education, discharge plan, follow up and management at community level are variable and sub optimal. Limited or poor patient participation and involvement in self-care is also a major factor in leading to poor outcome in HF.
As such, there has been much interest in identifying effective methods to improve the quality of care for HF patients while reducing costs. An effective management strategy and a balanced approach is the much needed.